Global Cancer Biologics Market Growth (Status and Outlook) 2023-2029

March 2023 | 101 pages | ID: G5F1B85DE45EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

Cancer Biologic is a medicinal preparation created by a biological process, it is used to treatment and remission cancer symptoms.

LPI (LP Information)' newest research report, the “Cancer Biologics Industry Forecast” looks at past sales and reviews total world Cancer Biologics sales in 2022, providing a comprehensive analysis by region and market sector of projected Cancer Biologics sales for 2023 through 2029. With Cancer Biologics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cancer Biologics industry.

This Insight Report provides a comprehensive analysis of the global Cancer Biologics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Cancer Biologics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Cancer Biologics market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cancer Biologics and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cancer Biologics.

The global Cancer Biologics market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Cancer Biologics is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Cancer Biologics is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Cancer Biologics is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Cancer Biologics players cover Roche, Novartis, Eli Lilly, Sanofi, Celgene, Pfizer, Bayer, Johnson & Johnson and Bristol-Myers Squibb, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Cancer Biologics market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type

• Monoclonal Antibodies
• Vaccines
• Cell and Gene Therapy
• Others

Segmentation by application

• Hospitals
• Clinics
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Roche
• Novartis
• Eli Lilly
• Sanofi
• Celgene
• Pfizer
• Bayer
• Johnson & Johnson
• Bristol-Myers Squibb
• Merck
• Amgen

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Cancer Biologics Market Size 2018-2029
  2.1.2 Cancer Biologics Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Cancer Biologics Segment by Type
  2.2.1 Monoclonal Antibodies
  2.2.2 Vaccines
  2.2.3 Cell and Gene Therapy
  2.2.4 Others
2.3 Cancer Biologics Market Size by Type
  2.3.1 Cancer Biologics Market Size CAGR by Type (2018 VS 2022 VS 2029)
  2.3.2 Global Cancer Biologics Market Size Market Share by Type (2018-2023)
2.4 Cancer Biologics Segment by Application
  2.4.1 Hospitals
  2.4.2 Clinics
  2.4.3 Others
2.5 Cancer Biologics Market Size by Application
  2.5.1 Cancer Biologics Market Size CAGR by Application (2018 VS 2022 VS 2029)
  2.5.2 Global Cancer Biologics Market Size Market Share by Application (2018-2023)

3 CANCER BIOLOGICS MARKET SIZE BY PLAYER

3.1 Cancer Biologics Market Size Market Share by Players
  3.1.1 Global Cancer Biologics Revenue by Players (2018-2023)
  3.1.2 Global Cancer Biologics Revenue Market Share by Players (2018-2023)
3.2 Global Cancer Biologics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 CANCER BIOLOGICS BY REGIONS

4.1 Cancer Biologics Market Size by Regions (2018-2023)
4.2 Americas Cancer Biologics Market Size Growth (2018-2023)
4.3 APAC Cancer Biologics Market Size Growth (2018-2023)
4.4 Europe Cancer Biologics Market Size Growth (2018-2023)
4.5 Middle East & Africa Cancer Biologics Market Size Growth (2018-2023)

5 AMERICAS

5.1 Americas Cancer Biologics Market Size by Country (2018-2023)
5.2 Americas Cancer Biologics Market Size by Type (2018-2023)
5.3 Americas Cancer Biologics Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Cancer Biologics Market Size by Region (2018-2023)
6.2 APAC Cancer Biologics Market Size by Type (2018-2023)
6.3 APAC Cancer Biologics Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Cancer Biologics by Country (2018-2023)
7.2 Europe Cancer Biologics Market Size by Type (2018-2023)
7.3 Europe Cancer Biologics Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Cancer Biologics by Region (2018-2023)
8.2 Middle East & Africa Cancer Biologics Market Size by Type (2018-2023)
8.3 Middle East & Africa Cancer Biologics Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL CANCER BIOLOGICS MARKET FORECAST

10.1 Global Cancer Biologics Forecast by Regions (2024-2029)
  10.1.1 Global Cancer Biologics Forecast by Regions (2024-2029)
  10.1.2 Americas Cancer Biologics Forecast
  10.1.3 APAC Cancer Biologics Forecast
  10.1.4 Europe Cancer Biologics Forecast
  10.1.5 Middle East & Africa Cancer Biologics Forecast
10.2 Americas Cancer Biologics Forecast by Country (2024-2029)
  10.2.1 United States Cancer Biologics Market Forecast
  10.2.2 Canada Cancer Biologics Market Forecast
  10.2.3 Mexico Cancer Biologics Market Forecast
  10.2.4 Brazil Cancer Biologics Market Forecast
10.3 APAC Cancer Biologics Forecast by Region (2024-2029)
  10.3.1 China Cancer Biologics Market Forecast
  10.3.2 Japan Cancer Biologics Market Forecast
  10.3.3 Korea Cancer Biologics Market Forecast
  10.3.4 Southeast Asia Cancer Biologics Market Forecast
  10.3.5 India Cancer Biologics Market Forecast
  10.3.6 Australia Cancer Biologics Market Forecast
10.4 Europe Cancer Biologics Forecast by Country (2024-2029)
  10.4.1 Germany Cancer Biologics Market Forecast
  10.4.2 France Cancer Biologics Market Forecast
  10.4.3 UK Cancer Biologics Market Forecast
  10.4.4 Italy Cancer Biologics Market Forecast
  10.4.5 Russia Cancer Biologics Market Forecast
10.5 Middle East & Africa Cancer Biologics Forecast by Region (2024-2029)
  10.5.1 Egypt Cancer Biologics Market Forecast
  10.5.2 South Africa Cancer Biologics Market Forecast
  10.5.3 Israel Cancer Biologics Market Forecast
  10.5.4 Turkey Cancer Biologics Market Forecast
  10.5.5 GCC Countries Cancer Biologics Market Forecast
10.6 Global Cancer Biologics Forecast by Type (2024-2029)
10.7 Global Cancer Biologics Forecast by Application (2024-2029)

11 KEY PLAYERS ANALYSIS

11.1 Roche
  11.1.1 Roche Company Information
  11.1.2 Roche Cancer Biologics Product Offered
  11.1.3 Roche Cancer Biologics Revenue, Gross Margin and Market Share (2018-2023)
  11.1.4 Roche Main Business Overview
  11.1.5 Roche Latest Developments
11.2 Novartis
  11.2.1 Novartis Company Information
  11.2.2 Novartis Cancer Biologics Product Offered
  11.2.3 Novartis Cancer Biologics Revenue, Gross Margin and Market Share (2018-2023)
  11.2.4 Novartis Main Business Overview
  11.2.5 Novartis Latest Developments
11.3 Eli Lilly
  11.3.1 Eli Lilly Company Information
  11.3.2 Eli Lilly Cancer Biologics Product Offered
  11.3.3 Eli Lilly Cancer Biologics Revenue, Gross Margin and Market Share (2018-2023)
  11.3.4 Eli Lilly Main Business Overview
  11.3.5 Eli Lilly Latest Developments
11.4 Sanofi
  11.4.1 Sanofi Company Information
  11.4.2 Sanofi Cancer Biologics Product Offered
  11.4.3 Sanofi Cancer Biologics Revenue, Gross Margin and Market Share (2018-2023)
  11.4.4 Sanofi Main Business Overview
  11.4.5 Sanofi Latest Developments
11.5 Celgene
  11.5.1 Celgene Company Information
  11.5.2 Celgene Cancer Biologics Product Offered
  11.5.3 Celgene Cancer Biologics Revenue, Gross Margin and Market Share (2018-2023)
  11.5.4 Celgene Main Business Overview
  11.5.5 Celgene Latest Developments
11.6 Pfizer
  11.6.1 Pfizer Company Information
  11.6.2 Pfizer Cancer Biologics Product Offered
  11.6.3 Pfizer Cancer Biologics Revenue, Gross Margin and Market Share (2018-2023)
  11.6.4 Pfizer Main Business Overview
  11.6.5 Pfizer Latest Developments
11.7 Bayer
  11.7.1 Bayer Company Information
  11.7.2 Bayer Cancer Biologics Product Offered
  11.7.3 Bayer Cancer Biologics Revenue, Gross Margin and Market Share (2018-2023)
  11.7.4 Bayer Main Business Overview
  11.7.5 Bayer Latest Developments
11.8 Johnson & Johnson
  11.8.1 Johnson & Johnson Company Information
  11.8.2 Johnson & Johnson Cancer Biologics Product Offered
  11.8.3 Johnson & Johnson Cancer Biologics Revenue, Gross Margin and Market Share (2018-2023)
  11.8.4 Johnson & Johnson Main Business Overview
  11.8.5 Johnson & Johnson Latest Developments
11.9 Bristol-Myers Squibb
  11.9.1 Bristol-Myers Squibb Company Information
  11.9.2 Bristol-Myers Squibb Cancer Biologics Product Offered
  11.9.3 Bristol-Myers Squibb Cancer Biologics Revenue, Gross Margin and Market Share (2018-2023)
  11.9.4 Bristol-Myers Squibb Main Business Overview
  11.9.5 Bristol-Myers Squibb Latest Developments
11.10 Merck
  11.10.1 Merck Company Information
  11.10.2 Merck Cancer Biologics Product Offered
  11.10.3 Merck Cancer Biologics Revenue, Gross Margin and Market Share (2018-2023)
  11.10.4 Merck Main Business Overview
  11.10.5 Merck Latest Developments
11.11 Amgen
  11.11.1 Amgen Company Information
  11.11.2 Amgen Cancer Biologics Product Offered
  11.11.3 Amgen Cancer Biologics Revenue, Gross Margin and Market Share (2018-2023)
  11.11.4 Amgen Main Business Overview
  11.11.5 Amgen Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Cancer Biologics Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Monoclonal Antibodies
Table 3. Major Players of Vaccines
Table 4. Major Players of Cell and Gene Therapy
Table 5. Major Players of Others
Table 6. Cancer Biologics Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 7. Global Cancer Biologics Market Size by Type (2018-2023) & ($ Millions)
Table 8. Global Cancer Biologics Market Size Market Share by Type (2018-2023)
Table 9. Cancer Biologics Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 10. Global Cancer Biologics Market Size by Application (2018-2023) & ($ Millions)
Table 11. Global Cancer Biologics Market Size Market Share by Application (2018-2023)
Table 12. Global Cancer Biologics Revenue by Players (2018-2023) & ($ Millions)
Table 13. Global Cancer Biologics Revenue Market Share by Player (2018-2023)
Table 14. Cancer Biologics Key Players Head office and Products Offered
Table 15. Cancer Biologics Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Cancer Biologics Market Size by Regions 2018-2023 & ($ Millions)
Table 19. Global Cancer Biologics Market Size Market Share by Regions (2018-2023)
Table 20. Global Cancer Biologics Revenue by Country/Region (2018-2023) & ($ millions)
Table 21. Global Cancer Biologics Revenue Market Share by Country/Region (2018-2023)
Table 22. Americas Cancer Biologics Market Size by Country (2018-2023) & ($ Millions)
Table 23. Americas Cancer Biologics Market Size Market Share by Country (2018-2023)
Table 24. Americas Cancer Biologics Market Size by Type (2018-2023) & ($ Millions)
Table 25. Americas Cancer Biologics Market Size Market Share by Type (2018-2023)
Table 26. Americas Cancer Biologics Market Size by Application (2018-2023) & ($ Millions)
Table 27. Americas Cancer Biologics Market Size Market Share by Application (2018-2023)
Table 28. APAC Cancer Biologics Market Size by Region (2018-2023) & ($ Millions)
Table 29. APAC Cancer Biologics Market Size Market Share by Region (2018-2023)
Table 30. APAC Cancer Biologics Market Size by Type (2018-2023) & ($ Millions)
Table 31. APAC Cancer Biologics Market Size Market Share by Type (2018-2023)
Table 32. APAC Cancer Biologics Market Size by Application (2018-2023) & ($ Millions)
Table 33. APAC Cancer Biologics Market Size Market Share by Application (2018-2023)
Table 34. Europe Cancer Biologics Market Size by Country (2018-2023) & ($ Millions)
Table 35. Europe Cancer Biologics Market Size Market Share by Country (2018-2023)
Table 36. Europe Cancer Biologics Market Size by Type (2018-2023) & ($ Millions)
Table 37. Europe Cancer Biologics Market Size Market Share by Type (2018-2023)
Table 38. Europe Cancer Biologics Market Size by Application (2018-2023) & ($ Millions)
Table 39. Europe Cancer Biologics Market Size Market Share by Application (2018-2023)
Table 40. Middle East & Africa Cancer Biologics Market Size by Region (2018-2023) & ($ Millions)
Table 41. Middle East & Africa Cancer Biologics Market Size Market Share by Region (2018-2023)
Table 42. Middle East & Africa Cancer Biologics Market Size by Type (2018-2023) & ($ Millions)
Table 43. Middle East & Africa Cancer Biologics Market Size Market Share by Type (2018-2023)
Table 44. Middle East & Africa Cancer Biologics Market Size by Application (2018-2023) & ($ Millions)
Table 45. Middle East & Africa Cancer Biologics Market Size Market Share by Application (2018-2023)
Table 46. Key Market Drivers & Growth Opportunities of Cancer Biologics
Table 47. Key Market Challenges & Risks of Cancer Biologics
Table 48. Key Industry Trends of Cancer Biologics
Table 49. Global Cancer Biologics Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 50. Global Cancer Biologics Market Size Market Share Forecast by Regions (2024-2029)
Table 51. Global Cancer Biologics Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 52. Global Cancer Biologics Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 53. Roche Details, Company Type, Cancer Biologics Area Served and Its Competitors
Table 54. Roche Cancer Biologics Product Offered
Table 55. Roche Cancer Biologics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 56. Roche Main Business
Table 57. Roche Latest Developments
Table 58. Novartis Details, Company Type, Cancer Biologics Area Served and Its Competitors
Table 59. Novartis Cancer Biologics Product Offered
Table 60. Novartis Main Business
Table 61. Novartis Cancer Biologics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 62. Novartis Latest Developments
Table 63. Eli Lilly Details, Company Type, Cancer Biologics Area Served and Its Competitors
Table 64. Eli Lilly Cancer Biologics Product Offered
Table 65. Eli Lilly Main Business
Table 66. Eli Lilly Cancer Biologics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 67. Eli Lilly Latest Developments
Table 68. Sanofi Details, Company Type, Cancer Biologics Area Served and Its Competitors
Table 69. Sanofi Cancer Biologics Product Offered
Table 70. Sanofi Main Business
Table 71. Sanofi Cancer Biologics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 72. Sanofi Latest Developments
Table 73. Celgene Details, Company Type, Cancer Biologics Area Served and Its Competitors
Table 74. Celgene Cancer Biologics Product Offered
Table 75. Celgene Main Business
Table 76. Celgene Cancer Biologics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 77. Celgene Latest Developments
Table 78. Pfizer Details, Company Type, Cancer Biologics Area Served and Its Competitors
Table 79. Pfizer Cancer Biologics Product Offered
Table 80. Pfizer Main Business
Table 81. Pfizer Cancer Biologics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 82. Pfizer Latest Developments
Table 83. Bayer Details, Company Type, Cancer Biologics Area Served and Its Competitors
Table 84. Bayer Cancer Biologics Product Offered
Table 85. Bayer Main Business
Table 86. Bayer Cancer Biologics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 87. Bayer Latest Developments
Table 88. Johnson & Johnson Details, Company Type, Cancer Biologics Area Served and Its Competitors
Table 89. Johnson & Johnson Cancer Biologics Product Offered
Table 90. Johnson & Johnson Main Business
Table 91. Johnson & Johnson Cancer Biologics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 92. Johnson & Johnson Latest Developments
Table 93. Bristol-Myers Squibb Details, Company Type, Cancer Biologics Area Served and Its Competitors
Table 94. Bristol-Myers Squibb Cancer Biologics Product Offered
Table 95. Bristol-Myers Squibb Main Business
Table 96. Bristol-Myers Squibb Cancer Biologics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 97. Bristol-Myers Squibb Latest Developments
Table 98. Merck Details, Company Type, Cancer Biologics Area Served and Its Competitors
Table 99. Merck Cancer Biologics Product Offered
Table 100. Merck Main Business
Table 101. Merck Cancer Biologics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 102. Merck Latest Developments
Table 103. Amgen Details, Company Type, Cancer Biologics Area Served and Its Competitors
Table 104. Amgen Cancer Biologics Product Offered
Table 105. Amgen Cancer Biologics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 106. Amgen Main Business
Table 107. Amgen Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Cancer Biologics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Cancer Biologics Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Cancer Biologics Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Cancer Biologics Sales Market Share by Country/Region (2022)
Figure 8. Cancer Biologics Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Cancer Biologics Market Size Market Share by Type in 2022
Figure 10. Cancer Biologics in Hospitals
Figure 11. Global Cancer Biologics Market: Hospitals (2018-2023) & ($ Millions)
Figure 12. Cancer Biologics in Clinics
Figure 13. Global Cancer Biologics Market: Clinics (2018-2023) & ($ Millions)
Figure 14. Cancer Biologics in Others
Figure 15. Global Cancer Biologics Market: Others (2018-2023) & ($ Millions)
Figure 16. Global Cancer Biologics Market Size Market Share by Application in 2022
Figure 17. Global Cancer Biologics Revenue Market Share by Player in 2022
Figure 18. Global Cancer Biologics Market Size Market Share by Regions (2018-2023)
Figure 19. Americas Cancer Biologics Market Size 2018-2023 ($ Millions)
Figure 20. APAC Cancer Biologics Market Size 2018-2023 ($ Millions)
Figure 21. Europe Cancer Biologics Market Size 2018-2023 ($ Millions)
Figure 22. Middle East & Africa Cancer Biologics Market Size 2018-2023 ($ Millions)
Figure 23. Americas Cancer Biologics Value Market Share by Country in 2022
Figure 24. United States Cancer Biologics Market Size Growth 2018-2023 ($ Millions)
Figure 25. Canada Cancer Biologics Market Size Growth 2018-2023 ($ Millions)
Figure 26. Mexico Cancer Biologics Market Size Growth 2018-2023 ($ Millions)
Figure 27. Brazil Cancer Biologics Market Size Growth 2018-2023 ($ Millions)
Figure 28. APAC Cancer Biologics Market Size Market Share by Region in 2022
Figure 29. APAC Cancer Biologics Market Size Market Share by Type in 2022
Figure 30. APAC Cancer Biologics Market Size Market Share by Application in 2022
Figure 31. China Cancer Biologics Market Size Growth 2018-2023 ($ Millions)
Figure 32. Japan Cancer Biologics Market Size Growth 2018-2023 ($ Millions)
Figure 33. Korea Cancer Biologics Market Size Growth 2018-2023 ($ Millions)
Figure 34. Southeast Asia Cancer Biologics Market Size Growth 2018-2023 ($ Millions)
Figure 35. India Cancer Biologics Market Size Growth 2018-2023 ($ Millions)
Figure 36. Australia Cancer Biologics Market Size Growth 2018-2023 ($ Millions)
Figure 37. Europe Cancer Biologics Market Size Market Share by Country in 2022
Figure 38. Europe Cancer Biologics Market Size Market Share by Type (2018-2023)
Figure 39. Europe Cancer Biologics Market Size Market Share by Application (2018-2023)
Figure 40. Germany Cancer Biologics Market Size Growth 2018-2023 ($ Millions)
Figure 41. France Cancer Biologics Market Size Growth 2018-2023 ($ Millions)
Figure 42. UK Cancer Biologics Market Size Growth 2018-2023 ($ Millions)
Figure 43. Italy Cancer Biologics Market Size Growth 2018-2023 ($ Millions)
Figure 44. Russia Cancer Biologics Market Size Growth 2018-2023 ($ Millions)
Figure 45. Middle East & Africa Cancer Biologics Market Size Market Share by Region (2018-2023)
Figure 46. Middle East & Africa Cancer Biologics Market Size Market Share by Type (2018-2023)
Figure 47. Middle East & Africa Cancer Biologics Market Size Market Share by Application (2018-2023)
Figure 48. Egypt Cancer Biologics Market Size Growth 2018-2023 ($ Millions)
Figure 49. South Africa Cancer Biologics Market Size Growth 2018-2023 ($ Millions)
Figure 50. Israel Cancer Biologics Market Size Growth 2018-2023 ($ Millions)
Figure 51. Turkey Cancer Biologics Market Size Growth 2018-2023 ($ Millions)
Figure 52. GCC Country Cancer Biologics Market Size Growth 2018-2023 ($ Millions)
Figure 53. Americas Cancer Biologics Market Size 2024-2029 ($ Millions)
Figure 54. APAC Cancer Biologics Market Size 2024-2029 ($ Millions)
Figure 55. Europe Cancer Biologics Market Size 2024-2029 ($ Millions)
Figure 56. Middle East & Africa Cancer Biologics Market Size 2024-2029 ($ Millions)
Figure 57. United States Cancer Biologics Market Size 2024-2029 ($ Millions)
Figure 58. Canada Cancer Biologics Market Size 2024-2029 ($ Millions)
Figure 59. Mexico Cancer Biologics Market Size 2024-2029 ($ Millions)
Figure 60. Brazil Cancer Biologics Market Size 2024-2029 ($ Millions)
Figure 61. China Cancer Biologics Market Size 2024-2029 ($ Millions)
Figure 62. Japan Cancer Biologics Market Size 2024-2029 ($ Millions)
Figure 63. Korea Cancer Biologics Market Size 2024-2029 ($ Millions)
Figure 64. Southeast Asia Cancer Biologics Market Size 2024-2029 ($ Millions)
Figure 65. India Cancer Biologics Market Size 2024-2029 ($ Millions)
Figure 66. Australia Cancer Biologics Market Size 2024-2029 ($ Millions)
Figure 67. Germany Cancer Biologics Market Size 2024-2029 ($ Millions)
Figure 68. France Cancer Biologics Market Size 2024-2029 ($ Millions)
Figure 69. UK Cancer Biologics Market Size 2024-2029 ($ Millions)
Figure 70. Italy Cancer Biologics Market Size 2024-2029 ($ Millions)
Figure 71. Russia Cancer Biologics Market Size 2024-2029 ($ Millions)
Figure 72. Spain Cancer Biologics Market Size 2024-2029 ($ Millions)
Figure 73. Egypt Cancer Biologics Market Size 2024-2029 ($ Millions)
Figure 74. South Africa Cancer Biologics Market Size 2024-2029 ($ Millions)
Figure 75. Israel Cancer Biologics Market Size 2024-2029 ($ Millions)
Figure 76. Turkey Cancer Biologics Market Size 2024-2029 ($ Millions)
Figure 77. GCC Countries Cancer Biologics Market Size 2024-2029 ($ Millions)
Figure 78. Global Cancer Biologics Market Size Market Share Forecast by Type (2024-2029)
Figure 79. Global Cancer Biologics Market Size Market Share Forecast by Application (2024-2029)